? Liver regeneration is a unique biological response in which normally quiescent, differentiated hepatocytes regain proliferative activity. Although the process involves the partially synchronized replication of more than 95% of hepatocytes, replication is strictly regulated and ceases when the liver regains its original mass. Understanding the mechanisms that initiate and regulate liver regeneration is of great scientific and clinical importance. In years 30 to 32 of this MERIT award we have demonstrated that Tumor Necrosis Factor (TNF) one of the main cytokines involved in the initiation of liver regeneration acts both through the NFKBIIL-GISTAT3 pathway that we have previously described, and by transactivating the EGF receptor (EGFR). Transactivation of EGFR involved the release of EGF ligands anchored into the cell membrane by the metalloproteinase TACE, triggering a mitogenic cascade involving ERK1/2 and PKB. We have also shown that one of these ligands, HB-EGF, whose expression is regulated by c-junlAP1 complexes, plays a key role in linking hepatocyte priming at the start of liver regeneration with cell cycle progression occurring many hours later. This application for extension of the MERIT project period is based on these findings and on other work demonstrating the role of NFKB and SOCS family genes in the initiation of liver regeneration. Placing emphasis on appropriate mouse models. and results from ongoing work, we designed experiments which address key issues regarding the mechanisms of liver regeneration:? 1) the control of hepatocyte survival and proliferation by GSH, 2) LPS receptor signaling as a triggering mechanism for liver regeneration,3) the role of SOCS-3 in preventing cytokine toxicity in the regenerating liver,4) the mechanisms by which c-junlAP-1 complexes control HB-EGF induction and 5) the role of cytokines in regulating differential hepatocyte and progenitor cell. The research plan for the extension of this MERIT award consists of 5 aims:? 1) Determine whether glutathione (GSH) and reactive oxygen species (ROS) production regulate growth and survival responses in the regenerating liver using Glutamate-LCysteine Ligase Modifier subunit knockout mouse (GCLM KO mice) as a model.? 2) Determine whether LPS signaling initiates liver regeneration by analysis of liver regeneration in MyD88, TLR4, TLR2 and CD14 KO mice.? 3) Investigate whether the lack of feedback regulation of the IL-GISTAT3 pathway in liver specific SOCS-3 KO mice prevents liver regeneration and triggers the acute phase response.? 4) Investigate the mechanism of induction of HB-EGF in the regenerating liver by cjunIAP-1 complexes, as a linkage between priming and cell cycle progression during liver regeneration.? 5) Determine whether IFNy in combination with TNF can change liver regeneration after PH from a hepatocyte to a liver precursor cell (oval cell) response.?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37CA023226-36
Application #
7214070
Study Section
Special Emphasis Panel (NSS)
Program Officer
Spalholz, Barbara A
Project Start
1977-08-01
Project End
2009-01-31
Budget Start
2007-02-01
Budget End
2008-01-31
Support Year
36
Fiscal Year
2007
Total Cost
$378,184
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wright, Jocelyn H; Johnson, Melissa M; Shimizu-Albergine, Masami et al. (2014) Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int J Cancer 134:778-88
Riehle, Kimberly J; Johnson, Melissa M; Johansson, Fredrik et al. (2014) Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation. Biochim Biophys Acta 1842:318-25
Obayashi, Yoko; Campbell, Jean S; Fausto, Nelson et al. (2013) Impaired lipid accumulation in the liver of Tsc2-heterozygous mice during liver regeneration. Biochem Biophys Res Commun 437:146-50
Riehle, Kimberly J; Haque, Jamil; McMahan, Ryan S et al. (2013) Sustained Glutathione Deficiency Interferes with the Liver Response to TNF-? and Liver Regeneration after Partial Hepatectomy in Mice. J Liver Disease Transplant 1:
McMahan, Ryan S; Riehle, Kimberly J; Fausto, Nelson et al. (2013) A disintegrin and metalloproteinase 17 regulates TNF and TNFR1 levels in inflammation and liver regeneration in mice. Am J Physiol Gastrointest Liver Physiol 305:G25-34
Fernando, Joan; Sancho, Patricia; Fernandez-Rodriguez, Conrado M et al. (2012) Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli. J Cell Physiol 227:1319-25
Okada, Hikari; Honda, Masao; Campbell, Jean S et al. (2012) Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res 72:4459-71
Caja, Laia; Bertran, Esther; Campbell, Jean et al. (2011) The transforming growth factor-beta (TGF-?) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells. J Cell Physiol 226:1214-23
Riehle, Kimberly J; Dan, Yock Y; Campbell, Jean S et al. (2011) New concepts in liver regeneration. J Gastroenterol Hepatol 26 Suppl 1:203-12
Caja, Laia; Sancho, Patricia; Bertran, Esther et al. (2011) The tyrphostin AG1478 inhibits proliferation and induces death of liver tumor cells through EGF receptor-dependent and independent mechanisms. Biochem Pharmacol 82:1583-92

Showing the most recent 10 out of 85 publications